CUTANA Hia5 enzyme

Search documents
PACB Partners With EpiCypher to Advance Epigenomics Using Fiber-Seq
ZACKS· 2025-09-05 17:51
Key Takeaways PacBio and EpiCypher partner to accelerate epigenomics with the Fiber-Seq workflow.The deal combines PacBio's HiFi sequencing with EpiCypher's chromatin expertise.Fiber-Seq links genetic and epigenetic data, streamlining assays into one workflow.PacBio (PACB) recently entered into a strategic partnership with EpiCypher to accelerate advancements in epigenomics research through the adoption of its Fiber-Seq workflow. This collaboration brings together PacBio’s long-read sequencing technology wi ...
PacBio and EpiCypher Partner to Deliver Novel Insights into Epigenomics with Fiber-seq Workflow
Globenewswire· 2025-09-03 13:05
Core Insights - PacBio has announced a partnership with EpiCypher to integrate EpiCypher's CUTANA Hia5 enzyme into its Fiber-seq assays, enhancing the ability to study chromatin biology at single-molecule resolution [1][3] - The collaboration aims to advance research in gene regulation, particularly in the context of rare diseases and cancer, by providing a comprehensive view of genetic and epigenetic features in a single assay [2][3] Company Overview - PacBio is a leading life science technology company focused on developing advanced sequencing solutions to address complex genetic problems across various research applications, including oncology and infectious diseases [4] - The company’s HiFi long-read sequencing technology is designed to provide high-quality data for a wide range of genomic studies [4] Product Details - The CUTANA Hia5 enzyme is now commercially available in 8 and 24 reaction formats, along with a supported Fiber-seq protocol, enabling researchers to generate insights into gene regulation [3] - Fiber-seq is an advanced multi-omic whole genome sequencing assay that measures chromatin accessibility, DNA methylation, and DNA variation simultaneously, offering a more integrated approach compared to traditional methods [2][3] Research Implications - The partnership is expected to facilitate the interrogation of complex genomic regions that are difficult to analyze with short-read approaches, potentially leading to breakthroughs in understanding rare diseases [7] - By consolidating multiple assays into a single workflow, researchers can save time and resources while obtaining richer data, which is crucial for advancing biological research [7]